Randox, a supplier of biomarker discovery services for the development of new biomarker assays, companion diagnostics, and the manufacture of clinical diagnostic reagents, has recently developed QuantiPlasma Array, a monoclonal antibody microarray designed to assess the level of multiple proteins simultaneously in human plasma.

According to the company, each kit contains 300 unique monoclonal antibodies, making it possible to directly assess the plasma proteome dynamics of normal and disease state plasma samples for identification of novel biomarkers in conjunction with Randox’s Biochip Array Technology analyzer platform.